Boussard & Gavaudan Investment Management’s Zura Bio Limited Warrants ZURAW Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio ZURAW Stock Details ZURAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-187,500	Closed	-$85.8K	–	98
2024 Q2	$85.8K	Hold	187,500	–	–	0.01%	64
2024 Q1	$58.1K	Hold	187,500	–	–	0.01%	67
2023 Q4	$31.4K	Hold	187,500	–	–	0.01%	62
2023 Q3	$61.3K	Hold	187,500	–	–	0.01%	82
2023 Q2	$67K	Hold	187,500	–	–	0.01%	93
2023 Q1	$46.9K	Hold	187,500	–	–	﹤0.01%	97
2022 Q4	$18.2K	Hold	187,500	–	–	﹤0.01%	109
2022 Q3	$24	Hold	187,500	–	–	﹤0.01%	118
2022 Q2	$32	Buy	+187,500	New	+$50.8K	0.01%	101
2022 Q1	–	Sell	-187,500	Closed	-$96K	–	83
2021 Q4	$96K	Hold	187,500	–	–	0.01%	117
2021 Q3	$113	Buy	+187,500	New	+$109K	0.01%	109

Boussard & Gavaudan Investment Management's ZURAW Position: Q3 2024 in Review

Boussard & Gavaudan Investment Management sold out of Zura Bio Limited Warrants (ZURAW) in Q3 2024, closing a stake of 187,500 shares — an estimated $85.8K sold.

Boussard & Gavaudan Investment Management first reported a position in ZURAW in Q3 2021 and held it in 11 quarters. The position peaked at $96K in Q4 2021. 0 funds tracked by Wall St. Rank hold ZURAW as of Q3 2024.

Boussard & Gavaudan Investment Management reported no remaining Zura Bio Limited Warrants position as of Q3 2024 after selling out during the quarter.
Boussard & Gavaudan Investment Management sold 187,500 Zura Bio Limited Warrants shares in Q3 2024, an estimated $85.8K.
Boussard & Gavaudan Investment Management first reported a position in Zura Bio Limited Warrants in Q3 2021 and held it in 11 quarters.
Boussard & Gavaudan Investment Management's Zura Bio Limited Warrants position peaked at $96K in Q4 2021.
0 funds tracked by Wall St. Rank held Zura Bio Limited Warrants as of Q3 2024.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.